Clinical trial
Plasma-Based Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections
NCT03846804 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Plasma-Based Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections
- Lead sponsor
- Indiana University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2019
- Completion date
- June 2, 2022
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute hematogenous osteomyelitis, musculoskeletal infection, osteomyelitis, pyomyositis, septic arthritis